![]() |
Trials |
A multi-center, phase I/II study of BAY86-9766 in combination with gemcitabine in patients with locally advanced inoperable or metastatic pancreatic cancerCancer type: Pancreatic cancer Phase: II Principal Investigator: Dajani Olav Country: NO Keywords: Norway, Pancreatic cancer, MEK-inhibitor Status: Completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01251640?term=BAY86-9766&rank=4 |